Supernus Pharmaceuticals, Inc.
SUPN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $74 | $1 | $61 | $53 |
| Dep. & Amort. | $80 | $85 | $86 | $33 |
| Deferred Tax | -$20 | -$26 | -$26 | -$5 |
| Stock-Based Comp. | $28 | $27 | $18 | $18 |
| Change in WC | -$2 | -$9 | -$24 | $4 |
| Other Non-Cash | $12 | $33 | $4 | $25 |
| Operating Cash Flow | $172 | $111 | $117 | $127 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | -$0 | -$312 |
| Inv. Purchases | -$688 | -$102 | -$407 | -$312 |
| Inv. Sales/Matur. | $499 | $371 | $191 | $531 |
| Other Inv. Act. | $0 | $0 | $0 | $13 |
| Investing Cash Flow | -$190 | $269 | -$217 | -$82 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$403 | $0 | -$138 |
| Stock Issued | $15 | $7 | $12 | $7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | -$2 | -$23 | $0 |
| Financing Cash Flow | $12 | -$398 | -$10 | -$130 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | -$18 | -$110 | -$85 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75 | $93 | $203 | $289 |
| End Cash | $69 | $75 | $93 | $203 |
| Free Cash Flow | $171 | $111 | $116 | $125 |